MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.500
+0.040 (1.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
MEI Pharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 6.95 | 3.71 | 16.91 | 15.74 | 8.54 | 12.33 | Upgrade
|
| Short-Term Investments | 19.95 | 34.64 | 83.79 | 137.51 | 144.88 | 170.3 | Upgrade
|
| Cash & Short-Term Investments | 26.91 | 38.35 | 100.69 | 153.25 | 153.43 | 182.63 | Upgrade
|
| Cash Growth | -67.27% | -61.92% | -34.30% | -0.11% | -15.99% | 145.18% | Upgrade
|
| Accounts Receivable | - | - | 0.09 | 10.04 | 7.58 | 2.94 | Upgrade
|
| Receivables | - | - | 0.09 | 10.04 | 7.58 | 2.94 | Upgrade
|
| Prepaid Expenses | - | 1.05 | 4.6 | 3.83 | 3.81 | 2.65 | Upgrade
|
| Other Current Assets | 0.84 | 1.37 | 2.15 | - | - | 20.42 | Upgrade
|
| Total Current Assets | 27.75 | 40.77 | 107.53 | 167.13 | 164.82 | 208.64 | Upgrade
|
| Property, Plant & Equipment | 0.01 | 0.61 | 13.28 | 10.71 | 9.28 | 1.08 | Upgrade
|
| Total Assets | 27.75 | 41.38 | 120.81 | 177.84 | 174.1 | 209.73 | Upgrade
|
| Accounts Payable | 0.98 | 3.17 | 6.13 | 7.92 | 6.36 | 2.44 | Upgrade
|
| Accrued Expenses | 1.9 | 5.19 | 12.46 | 10.82 | 8.4 | 6.09 | Upgrade
|
| Current Portion of Leases | - | - | 1.43 | 0.87 | 0.93 | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.32 | 4.83 | 4.53 | 5.23 | Upgrade
|
| Total Current Liabilities | 2.87 | 8.36 | 20.34 | 24.44 | 20.21 | 13.76 | Upgrade
|
| Long-Term Leases | - | - | 11.3 | 8.77 | 7.37 | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | 64.55 | 90.61 | 74.7 | 78.43 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 1.6 | 22.36 | 40.48 | Upgrade
|
| Total Liabilities | 2.87 | 8.36 | 96.19 | 125.43 | 124.63 | 132.67 | Upgrade
|
| Additional Paid-In Capital | 421.1 | 421.24 | 430.62 | 426.57 | 369.17 | 355.45 | Upgrade
|
| Retained Earnings | -396.23 | -388.22 | -406 | -374.16 | -319.71 | -278.39 | Upgrade
|
| Shareholders' Equity | 24.88 | 33.02 | 24.62 | 52.41 | 49.47 | 77.06 | Upgrade
|
| Total Liabilities & Equity | 27.75 | 41.38 | 120.81 | 177.84 | 174.1 | 209.73 | Upgrade
|
| Total Debt | - | - | 12.73 | 9.64 | 8.3 | - | Upgrade
|
| Net Cash (Debt) | 26.91 | 38.35 | 87.97 | 143.61 | 145.13 | 182.63 | Upgrade
|
| Net Cash Growth | -61.47% | -56.41% | -38.75% | -1.05% | -20.53% | 145.18% | Upgrade
|
| Net Cash Per Share | 4.04 | 5.75 | 13.20 | 22.95 | 25.35 | 40.10 | Upgrade
|
| Filing Date Shares Outstanding | 6.66 | 6.66 | 6.66 | 6.66 | 5.63 | 5.63 | Upgrade
|
| Total Common Shares Outstanding | 6.66 | 6.66 | 6.66 | 6.66 | 5.63 | 5.58 | Upgrade
|
| Working Capital | 24.87 | 32.41 | 87.19 | 142.68 | 144.61 | 194.89 | Upgrade
|
| Book Value Per Share | 3.73 | 4.96 | 3.70 | 7.87 | 8.78 | 13.82 | Upgrade
|
| Tangible Book Value | 24.88 | 33.02 | 24.62 | 52.41 | 49.47 | 77.06 | Upgrade
|
| Tangible Book Value Per Share | 3.73 | 4.96 | 3.70 | 7.87 | 8.78 | 13.82 | Upgrade
|
| Machinery | 0.01 | 1.19 | 1.37 | 1.25 | 0.9 | 0.3 | Upgrade
|
| Leasehold Improvements | - | 0.97 | 0.97 | 1.05 | 0.94 | 0.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.